3D Systems Announces Appointment of Dr. Toby Cosgrove and Dr. Bon Ku as Members of its Medical Advisory Board
August 18 2022 - 4:05PM
3D Systems (NYSE:DDD) today announced the appointment of Dr. Toby
Cosgrove, former president & chief executive officer of the
Cleveland Clinic, and Dr. Bon Ku, director of the Health Design Lab
at Thomas Jefferson University, as the fourth and fifth members of
the company’s recently established Medical Advisory Board (MAB).
Dr. Cosgrove and Dr. Ku will join former Health & Human
Services Secretary Alex Azar, Dr. Stephen K. Klasko, and former
U.S. Secretary of Veterans Affairs David J. Shulkin as members of
the advisory board. The Board’s primary mission is to provide
strategic input, guidance, and recommendations for the company’s
expanding efforts in regenerative medicine.
Dr. Cosgrove has distinguished himself as a leader of one of the
world’s most recognized healthcare institutions, a renowned medical
practitioner, and as a forward-looking healthcare innovator. Having
been affiliated with the Cleveland Clinic healthcare system for
nearly 50 years, Dr. Cosgrove served as President and Chief
Executive Officer from 2004 to 2017 and is currently an Executive
Advisor to the Clinic. As President and CEO, Dr. Cosgrove oversaw a
$6 billion annual revenue institution comprised of the Cleveland
Clinic, over 20 Ohio-based hospitals, family health centers, and
surgical facilities, as well as Cleveland Clinic affiliates in
other U.S. states and internationally. During Dr. Cosgrove’s tenure
leading the Cleveland Clinic, it was ranked among the top three
hospitals in America by U.S. News and World Report, and he
championed a broad range of initiatives to improve clinical
outcomes, increase patient satisfaction, and focus the Clinic’s
delivery of health care services around specific organ systems and
diseases.
Prior to serving as the Cleveland Clinic’s top executive, Dr.
Cosgrove was a cardiac surgeon at the Clinic and served as Chairman
of its Department of Thoracic and Cardiovascular Surgery from 1989
to 2004. He has performed more than 22,000 operations over the
course of his career and is widely regarded as a pioneer in the
field of advanced surgical techniques. Deeply committed to medical
innovation and to applying new technologies for the benefit of
patients, Dr. Cosgrove has over 30 patents filed for new medical
and clinical products used in surgical environments.
Dr. Bon Ku has enjoyed a distinguished career as both a
practicing medical clinician and as a visionary proponent of using
technology-based innovations to solve pressing healthcare
challenges. Dr. Ku is the Marta and Robert Adelson Professor of
Medicine and Design at Thomas Jefferson University as well as an
emergency physician at the University’s Sidney Kimmel Medical
College.
Dr. Ku is widely regarded as an authority on accelerating
healthcare innovation through the use of modern technological tools
such as virtualization, digital modeling, prototyping, and additive
manufacturing. He is the co-founder and Director of Thomas
Jefferson University’s Health Design Lab, a unique institution that
works with medical students, researchers, and physicians to develop
new medical devices and innovative design concepts for the
healthcare sector. The Health Design Lab led by Dr. Ku features a
clinical 3D printing and bioprinting lab and is home to the
JeffSolves MedTech initiative, which serves as a center for the
incubation and commercialization of new medical technologies. Dr.
Ku is also the author of numerous peer-reviewed publications
focusing on the application of 3D-printed medical devices and
digital models to improve surgical outcomes, optimize treatments,
and make advancements in personalized medicine.
Commenting on the appointments of Drs. Cosgrove and Ku, 3D
Systems’ President and CEO, Dr. Jeffrey Graves stated, “We are
exceptionally pleased to welcome Dr. Cosgrove and Dr. Ku to our
Medical Advisory Board. These two professionals have impeccable
track records of combining hands-on medical practice experience
with a clear passion for utilizing innovative approaches and modern
technology to transform healthcare outcomes. Both Dr. Cosgrove and
Dr. Ku will be uniquely positioned to advise 3D Systems as we build
a world-class regenerative medicine business and pursue 3D
printing-based advancements in areas such as accelerated
pharmaceutical development, human tissue and organ printing,
medical device innovation, and personalized medicine.”
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as "believes," "belief," "expects," "may,"
"will," "estimates," "intends," "anticipates" or "plans" or the
negative of these terms or other comparable terminology.
Forward-looking statements are based upon management’s beliefs,
assumptions, and current expectations and may include comments as
to the company’s beliefs and expectations as to future events and
trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the control of the
company. The factors described under the headings "Forward-Looking
Statements" and "Risk Factors" in the company’s periodic filings
with the Securities and Exchange Commission, as well as other
factors, could cause actual results to differ materially from those
reflected or predicted in forward-looking statements. Although
management believes that the expectations reflected in the
forward-looking statements are reasonable, forward-looking
statements are not, and should not be relied upon as a guarantee of
future performance or results, nor will they necessarily prove to
be accurate indications of the times at which such performance or
results will be achieved. The forward-looking statements included
are made only as of the date of the statement. 3D Systems
undertakes no obligation to update or revise any forward-looking
statements made by management or on its behalf, whether as a result
of future developments, subsequent events or circumstances or
otherwise, except as required by law.
About 3D Systems More than 35 years ago, 3D
Systems brought the innovation of 3D printing to the manufacturing
industry. Today, as the leading additive manufacturing solutions
partner, we bring innovation, performance, and reliability to every
interaction - empowering our customers to create products and
business models never before possible. Thanks to our unique
offering of hardware, software, materials, and services, each
application-specific solution is powered by the expertise of our
application engineers who collaborate with customers to transform
how they deliver their products and services. 3D Systems’ solutions
address a variety of advanced applications in healthcare and
industrial markets such as medical and dental, aerospace &
defense, automotive, and durable goods. More information on the
company is available at www.3dsystems.com.
Investor Contact:
investor.relations@3dsystems.comMedia
Contact: press@3dsystems.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/2b14f06b-98f9-4c66-8c02-b57375cab66d
3D Systems (NYSE:DDD)
Historical Stock Chart
From Mar 2024 to Apr 2024
3D Systems (NYSE:DDD)
Historical Stock Chart
From Apr 2023 to Apr 2024